Brief: Enveric Biosciences Says Ongoing GLP Safety And Toxicology Program Of EB-373 Is Thus Far Proceeding On Time With Favorable Results
27/12/2023 13:52
Dec 27 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES INC - ONGOING GLP SAFETY AND
TOXICOLOGY
PROGRAM OF EB-373 IS THUS FAR PROCEEDING ON TIME WITH FAVORABLE
RESULTS
* ENVERIC BIOSCIENCES INC - COMPLETE ANALYSIS AND FINAL
REPORTING
FROM GLP TOXICOLOGY STUDIES OF EB-373 EXPECTED BY THE END OF Q1
2024
Source text for Eikon: ID:nBw1jy3Tfa
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003